Imre Berger, Professor of Biochemistry and Chemistry and Director of Bristol’s Max Planck Centre for Minimal Biology has been elected as a Fellow of the Academy of Medical Sciences for his outstanding contributions to biomedical science and notable discoveries during the COVID-19 pandemic.
Biodesign spinout company Ziylo has been acquired by global healthcare company Novo Nordisk in a deal that could exceed $800m.
Scientists have harnessed the potential of bacteria to help build advanced synthetic cells which mimic real life functionality.
Red blood cells that have been grown in a laboratory have now been transfused into another person in a world first clinical trial led by a UK team including University of Bristol researchers.
The University of Bristol is at the forefront of synthetic biology research, teaching and innovation.
Scientists have discovered why some coronaviruses are more likely to cause severe disease, which has remained a mystery, until now. Researchers of the University of Bristol-led study, published in Science Advances today [23 November], say their findings could lead to the development of a pan-coronavirus treatment to defeat all coronaviruses—from the 2002 SARS-CoV outbreak to Omicron, the current variant of SARS-CoV-2, as well as dangerous variants that may emerge in future.
Scientists from the Universities of Bristol and Hannover studying a naturally-produced compound that inspired the biggest selling family of commercial agricultural fungicides have, for the first time, discovered how this important class of compound is synthesised in nature. The findings could potentially be used in the future to enable a ‘pick and mix’ approach with combinations of enzymes to make designer biosynthetic pathways for new compounds that could help to control crop diseases.
The University of Bristol is part of a new £6.75 million national network to accelerate UK innovation. The Innovation Launchpad Network+ brings together leading universities, the Catapult Network and regional innovation ecosystems to enrich the exchange of ideas and knowledge across these organisations.
A ground-breaking new theatre production, to be premiered in Bristol, will plunge audiences into a moral dilemma examining the role – good and bad – science can play in our lives.
The German Ambassador to the UK, His Excellency Miguel Berger visited the University on Friday [11 November], to meet Professor Evelyn Welch, the University's Vice-Chancellor and President, to discuss opportunities for UK-Germany education and research collaboration.
